Venture Capital News: Breaking Venture Capital News, Comments and Articles. - Page: 4

09:13 EDT 27th March 2015 | BioPortfolio

Venture Capital News - Page: 4RSS

Read the latest Venture Capital News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Venture Capital.

Search or Follow Our Venture Capital - Page: 4 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Venture Capital - Page: 4 News.

Showing "venture capital" News Articles 76 to 100 of 7,600+

Wednesday 25th March 2015

CASI Pharmaceuticals Announces Initiation Of A Phase 2 Trial With ENMD-2076 In Triple-Negative Breast Cancer In China

  ROCKVILLE, Md., March 25, 2015 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China, announces that it has initiated a Phase 2 trial of its target therapy drug...

Tuesday 24th March 2015

Cellectis Prices Initial Public Offering of American Depositary Shares

Regulatory News: March 24, 2015 – Cellectis (Paris:ALCLS) (Alternext: ALCLS – Nasdaq Global Market: CLLS), a pioneering gene-editing company employing proprietary technologies to develop best-in-class products in the emerging field of immuno-oncology, today announced the pricing of its initial public offering of 5,500,000 American Depositary S...

Vtesse, Inc. Forms Scientific Advisory Board

GAITHERSBURG, Md., March 25, 2015 /PRNewswire/ -- Vtesse, Inc.,  a rare disease company focused on developing drugs for Niemann-Pick Disease Type C (NPC) and other severe diseases with great unmet need, announced today the formation of its Scientific Advisory Board (SAB).  Comprising experts from a range of fields including pediatrics, translational medicine, biomarker research and ...

Extenway Completes Debt Settlement and Second Tranche of a $2,915,600 Private Placement and Grants Options

MONTREAL, QUEBEC -- (Marketwired) -- 03/25/15 -- Extenway Solutions Inc. ("Extenway" or the "Company") (TSX VENTURE: EY) is pleased to announce the closing, as of March 25, 2015 (the "Closing Date"), of the following transactions: The Transactions The Second Tranche was completed as part of a larger offering of common shares of the Company for combined aggregate proceeds of $2,915,600 (the "Of...

Abattis Information to Be Available in S&P Capital IQ Market Access Program

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 03/25/15 -- Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTCQX: ATTBF)(CSE: ATT), a specialty biotechnology company with capabilities through its wholly-owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds and patented equipment to medicinal markets in North America, would like to ann...

Ventripoint Announces Resignation of Director

SEATTLE, WASHINGTON -- (Marketwired) -- 03/25/15 -- Ventripoint Diagnostics Ltd. ("Ventripoint") (TSX VENTURE: VPT) announces that Mr. Brad Harlow has resigned from the Board of Directors of the Company to focus on his duties as CEO of Cardiac Insight Inc. He is also continuing as President & CEO of PhysioSonics Inc. These companies, plus his work with CBC Partners LLC, a lending company, ar...

Aphria Successfully Amends License to Allow for Wholesale Shipping

LEAMINGTON, ONTARIO -- (Marketwired) -- 03/25/15 -- Aphria Inc. ("Aphria" or the "Company") (TSX VENTURE: APH) is pleased to announce that it has successfully amended its license with Health Canada to allow for wholesale shipping of medical marijuana in dried bud form. "We are pleased to be the first of the licensed producers in Canada to commence wholesale shipping," stated Vic Neufeld, Presid...

New corporate advisory practice for Australian tech companies

Corporate advisory house Cube Capital has just launched in Australia, with a plan to capitalise on the boom in tech and healthcare stocks and take them public.Cube Capital advises middle market Australian and international clients on investment banking transactions. The company is particularly focused on deals within the information technology, media, telecommunications, healthcare and life scienc...

First Choice Healthcare Solutions Exercises Right to Extend First Periodic Redemption Payment to Hillair Capital

MELBOURNE, FL -- (Marketwired) -- 03/25/15 -- First Choice Healthcare Solutions, Inc. (OTCQB: FCHS) ("FCHS" or "First Choice"), a diversified holding company focused on delivering clinically superior, patient-centric, multi-specialty care through state-of-the-art medical centers of excellence, today announced that it has elected to exercise its right to extend the first periodic redemption paymen...

CNL Healthcare Properties to Participate in NIC 2015 Capital and Business Strategies Forum

Orlando, Fla., March 25, 2015 (GLOBE NEWSWIRE) -- CNL Healthcare Properties is one of a select group of capital providers invited to participate in "Capital Connections," a unique networking event during the National Investment Center for Seniors Housing and Care (NIC) 2015 Capital and Business Strategies Forum being held in San Diego from March 31 to April 2.The NIC Capital and Business Strategi...

Knight Therapeutics' Secured Lending Strategy Validated by CRH Medical Corporation

MONTREAL, CANADA -- (Marketwired) -- 03/25/15 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or the "Company"), a leading Canadian specialty pharmaceutical company, announced today that it successfully helped finance CRH Medical Corporation's (TSX: CRH) (OTCQX: CRMMF) ("CRH") U.S. expansion as best evidenced by CRH's recent equity offering: CRH raised $27.37 million of equity at $3.40 per shar...

Fitch Affirms Tenet Healthcare on USPI Transaction; Revises Outlook to Negative

Fitch Ratings has affirmed the ratings of Tenet Healthcare Corp. (Tenet; NYSE: THC), including the 'B' long-term Issuer Default Rating (IDR). The Rating Outlook is revised to Negative from Stable. A full list of rating actions, which apply to approximately $13.8 billion of debt at Dec. 31, 2014, follows at the end of this release. The rat...

Town Sports International Holdings, Inc. Announces Agreements on Board Composition

On March 24, 2015, Town Sports International Holdings, Inc. (Nasdaq:CLUB) (“TSI” or the “Company”) announced that the Board of Directors unanimously approved, effective immediately, the appointment of each of Martin J. Annese, Jason M. Fish, Mark A. McEachen, Patrick Walsh and L. Spencer Wells as members of the Board, and the resignation of Paul N....

Retrophin Closes Public Offering of 7,866,000 Shares of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Retrophin, Inc. (NASDAQ:RTRX), a biopharmaceutical company focused on the discovery and development of drugs for the treatment of catastrophic diseases that are debilitating and often life-threatening, and for which there are currently limited patient options, today announced the closing of its previously announced underwritten public offering of 7,866,000 ...

Antibiotics Poised For ‘Breakthrough’-Style Changes At FDA, Venture Capitalist Say

Even if FDA already has authorities, legislation can energize agency, Third Rock Ventures’ Borisy tells Senate, adding limited population approval should be extended beyond antibiotics to other disease areas.

Diabetes start-up brings in cash and a partner

Recently started diabetes-focused start-up Semma Therapeutics announced 24 March that it has brought in $44m in Series A funding through a variety of investors, including Fidelity Biosciences, ARCH Ventures, MPM Capital and Medtronic.

Semma brings in $44mm through first round

Newly formed Semma Therapeutics raised $44mm in its Series A financing led by MPM Capital, which was joined by Fidelity Biosciences, ARCH Venture Partners, and Medtronic.

Vapogenix raises $5.1mm in Series B round

Pamoja Capital and GPG Venture led a $5.1mm Series B financing for Vapogenix Inc. (topically delivered non-narcotic pain medications).

Semma closes $44M series A round

Semma Therapeutics Inc. (Cambridge, Mass.) raised $44 million in a series A round led by existing investor MPM Capital. Existing investor Fidelity Biosciences and new investors ARCH Venture Partners and Medtronic Inc. (NYSE:MDT) also participated. Se...

GE Healthcare Building a Stronger Network in the Fight Against Cancer

New Omnyx-Clarient alliance enables collaboration in the cancer diagnosis process, empowers personalized therapeutics Amidst an estimated 70 percent increase in cancer diagnosis in the next two decades and an estimated 1.41 million misdiagnoses of cancer, healthcare providers and patients today face significant challenges. 1, 2, 3, 4, 5, 6 To he...

BRIEF-Newron authorized to allocate up to 1.3 mln shares to raise capital

* Announced that shareholders today authorized company to allocate up to 1.3 million shares to raise capital

Newron Shareholders Authorize Allocation of Additional Shares to Support Multiple Clinical Programs

Newron Pharmaceuticals S.p.A. (“Newron”), a research and development company focused on novel Central Nervous System (CNS) and pain therapies, announced that shareholders today authorized the Company to allocate up to 1.3 million shares to raise capital. “Newron is committed to bringing much needed new therapies to patients with CNS diseases...

Adaptive Center, the “David” in the Addiction Treatment Field, Goes up Against the Giants

Adaptive Center, a Miami-based addiction treatment center, was notified that it has earned the Gold Seal of Approval® for Behavioral Health Care Accreditation by The Joint Commission, the agency that accredits the best hospitals in the world. The Gold Seal of Approval® is a symbol of quality that reflects an organization’s capacity to

US gears up for wild (Canada) goose chase

Park rangers in the US capital are gearing up for a wild goose chase. Literally.

El Camino Hospital and Satellite Healthcare Complete Joint Venture Partnership to Strengthen Dialysis Service Offerings for Patients and the Community

El Camino Hospital, an acute-care, 443-bed, nonprofit and locally governed corporation with campuses in Mountain View and Los Gatos, Calif., and Satellite Healthcare, a leading nonprofit dialysis-services provider headquartered in San Jose, Calif., with more than 30 dialysis centers in the Bay Area and more than 70 nationwide, today announced they have ent...

Search BioPortfolio:

News Quicklinks